Thomas WALTER

206
Documents

Publications

Publications

LUNG CARCINOIDS (Lung Neuroendocrine Tumors)

Anna Koumarianou , Jules Derks , Marina Tsoli , Marco Volante , Lynnette Fernandez-Cuesta et al.

Endocrine reviews, 2026, ⟨10.1210/endrev/bnag001⟩

Article dans une revue hal-05457268v1

Transcatheter valve replacement in carcinoid heart disease: A potential change of paradigm

Marie-Anne Barbier , Laura Gerard , Daniel Grinberg , Laurent François , Thomas Walter et al.

Interdisciplinary Cardiovascular and Thoracic Surgery, 2026, ⟨10.1093/icvts/ivag001⟩

Article dans une revue hal-05451474v1

Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial

Thomas Pierre Walter , Julien Mazieres , Josiane Otto , Hervé Lena , Côme Lepage et al.

Journal of Clinical Oncology, 2026, pp.JCO2501657. ⟨10.1200/JCO-25-01657⟩

Article dans une revue hal-05536623v1

PRRT plus holmium‐166‐ SIRT ( HEPAR PLuS ) versus PRRT ‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis

W. Veldhuis , Thomas Walter , D. de Vries-Huizing , J. Theysohn , S. Barton et al.

Journal of Neuroendocrinology, 2025, pp.e70034. ⟨10.1111/jne.70034⟩

Article dans une revue hal-05056032v1

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research

L. Fernandez-Cuesta , C. Voegele , B. Hemon , K. Alcala , D. Aune et al.

ESMO Rare Cancers, 2025, 2, pp.100014. ⟨10.1016/j.esmorc.2025.100014⟩

Article dans une revue hal-05165346v1

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Kohei Shitara , Sylvie Lorenzen , Jin Li , Yuxian Bai , Manuel González Fernández et al.

Journal of Clinical Oncology, 2025, ⟨10.1200/JCO-25-00748⟩

Article dans une revue hal-05106538v1

Cold snaring vs. standard forceps biopsy in sampling colorectal cancer: a comparative case report

Simona Agazzi , Eukene Rojo , Elena de Cristofaro , Jérôme Rivory , Thomas Walter et al.

Endoscopy, 2025, 57 (S 01), pp.E190-E191. ⟨10.1055/a-2535-1929⟩

Article dans une revue hal-04987279v1

Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial

S. Ganame , Thomas Walter , Alain Durand , A. Lièvre , D. Tougeron et al.

European Journal of Cancer, 2025, pp.115450. ⟨10.1016/j.ejca.2025.115450⟩

Article dans une revue hal-05062946v1

Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits

Romain L’huillier , Gilles Poncet , Arnaud Pasquer , Thomas Walter , Catherine Lombard-Bohas et al.

Endocrine Oncology, 2025, 5 (1), ⟨10.1530/EO-24-0056⟩

Article dans une revue hal-04987278v1
Deposit thumbnail

Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors

Céline Patte , Roxane Pommier , Anthony Ferrari , Felicia Fei-Lei Chung , Maria Ouzounova et al.

Nature Communications, 2025, 16 (1), pp.2197. ⟨10.1038/s41467-025-57305-8⟩

Article dans une revue hal-04987274v1

Basic science and translational implications of current knowledge on neuroendocrine tumors

Lynnette Fernandez-Cuesta , Nicolas Alcala , Emilie Mathian , Jules Derks , Chrissie Thirlwell et al.

The Journal of clinical investigation, 2025, 135 (5), pp.960-971. ⟨10.1172/JCI186702⟩

Article dans une revue hal-04987277v1
Deposit thumbnail

A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)

Jaume Capdevila , Virginia Pubul , Urbano Anido , Thomas Walter , Javier Molina-Cerrillo et al.

BMC Cancer, 2025, 25 (1), pp.613. ⟨10.1186/s12885-025-13941-3⟩

Article dans une revue hal-05022367v1
Deposit thumbnail

PFMG2025–integrating genomic medicine into the national healthcare system in France

Caroline Abadie , Aldja Abderrahmane , Ouarda Abdous , Carine Abel , Oanez Ackermann et al.

The Lancet Regional Health - Europe, 2025, 50, pp.101183. ⟨10.1016/j.lanepe.2024.101183⟩

Article dans une revue hal-04988732v1
Deposit thumbnail

Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology

Guillaume Pontarollo , Maxime Bonjour , Thomas Walter , Mathieu Pioche , Pierre-Marie Lavrut et al.

Virchows Archiv, 2024, ⟨10.1007/s00428-023-03722-3⟩

Article dans une revue hal-04490334v1
Deposit thumbnail

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study

Margaux Mekkan-Bouv Hez , Lea Derbey , Louis de Mestier , Lorenzo D , Thomas Walter et al.

International Journal of Surgery, 2024, ⟨10.1097/js9.0000000000001382⟩

Article dans une revue hal-04575949v1

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Thomas Walter , Thierry Lecomte , Julien Hadoux , Patricia Niccoli , Léa Saban-Roche et al.

Journal of Clinical Oncology, 2024, ⟨10.1200/JCO.23.02724⟩

Article dans une revue hal-04886197v1

Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177 Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network

Laure Al Mansour , Louis de Mestier , Magalie Haissaguerre , Pauline Afchain , Julien Hadoux et al.

Journal of Nuclear Medicine, 2024, 65 (2), pp.258-263. ⟨10.2967/jnumed.123.266063⟩

Article dans une revue hal-04465202v1
Deposit thumbnail

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project

É. Mathian , Y. Drouet , A. Sexton-Oates , M.G. Papotti , G. Pelosi et al.

ESMO Open, 2024, 9 (6), pp.103591. ⟨10.1016/j.esmoop.2024.103591⟩

Article dans une revue hal-04655442v1
Deposit thumbnail

Duodenal neuroendocrine tumor successfully removed by endoscopic submucosal dissection with adaptative traction device

Elena de Cristofaro , Jérôme Rivory , Thomas Walter , Jérémie Jacques , Timothée Wallenhorst et al.

Endoscopy, 2024, 56 (S 01), pp.E317-E318. ⟨10.1055/a-2291-9448⟩

Article dans une revue hal-04647923v1

Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors

Loïc Cheminel , Alexandru Lupu , Timothée Wallenhorst , Vincent Lepilliez , Sarah Leblanc et al.

The American Journal of Gastroenterology, 2024, 119 (2), pp.378-381. ⟨10.14309/ajg.0000000000002516⟩

Article dans une revue hal-04435460v1

Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease

Antoine Lecoeur , Rita-Maria Sfeir , Laura Gerard , Myriam Souifi , Johanna Damour et al.

European Journal of Endocrinology, 2024, 191 (6), pp.570-578. ⟨10.1093/ejendo/lvae150⟩

Article dans une revue hal-04886186v1

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network

Aurelien Fosse , Julien Hadoux , Paul Girot , Amandine Beron , Pauline Afchain et al.

Journal of Nuclear Medicine, 2024, pp.jnumed.123.267363. ⟨10.2967/jnumed.123.267363⟩

Article dans une revue hal-04675518v1

French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1

Pierre Goudet , Guillaume Cadiot , Anne Barlier , Eric Baudin , Françoise Borson-Chazot et al.

Annales d'Endocrinologie = Annals of Endocrinology, 2024, 85 (1), pp.2-19. ⟨10.1016/j.ando.2023.09.003⟩

Article dans une revue hal-04490329v1

Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms

Laura Gerard , Céline Patte , Laurence Chardon , Valérie Hervieu , Léa Payen et al.

Endocrine-Related Cancer, 2024, 31 (6), ⟨10.1530/ERC-24-0052⟩

Article dans une revue hal-04638761v1
Deposit thumbnail

Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review

Benjamin Chevalier , Lucie Coppin , Pauline Romanet , Thomas Cuny , Jean-Christophe Maïza et al.

Journal of Clinical Endocrinology and Metabolism, 2024, ⟨10.1210/clinem/dgae055⟩

Article dans une revue hal-04522637v1

Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group

Benjamin Chevalier , Delphine Bonnet , Come Lepage , Marine Perrier , Françoise Borson-Chazot et al.

Journal of the Endocrine Society, 2024, 8 (7), pp.188-194. ⟨10.1210/jendso/bvae102⟩

Article dans une revue hal-04934196v1

Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network

Lucie Duponchelle , Eric Baudin , Fabien Subtil , Christine Do Cao , Eric Dansin et al.

Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13331⟩

Article dans une revue hal-04517673v1

ASO Visual Abstract: The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery—A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier et al.

Annals of Surgical Oncology, 2023, 31 (2), pp.1144-1145. ⟨10.1245/s10434-023-14382-7⟩

Article dans une revue hal-04490348v1

Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network

Marine Perrier , Mathias Brugel , Laura Gerard , Bernard Goichot , Astrid Lièvre et al.

European Journal of Endocrinology, 2023, European Journal of Endocrinology, 189 (6), pp.575-583. ⟨10.1093/ejendo/lvad157⟩

Article dans une revue hal-04338301v1
Deposit thumbnail

From netrin‐1‐targeted <scp>SPECT</scp> / <scp>CT</scp> to internal radiotherapy for management of advanced solid tumors

David Kryza , Jennifer Wischhusen , Mathieu Richaud , Maëva Hervieu , Jacqueline Sidi Boumedine et al.

EMBO Molecular Medicine, 2023, 15, ⟨10.15252/emmm.202216732⟩

Article dans une revue hal-04107206v1

OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel

Vincent Hautefeuille , Thomas Walter , Christine Do Cao , Romain Coriat , Sophie Dominguez et al.

European Journal of Endocrinology, 2023, 189 (2), pp.281-289. ⟨10.1093/ejendo/lvad094⟩

Article dans une revue hal-04489831v1

COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study

Nicola Fazio , Lorenzo Gervaso , Thorvardur Halfdanarson , Mohamad Sonbol , Rachel Eiring et al.

Endocrine-Related Cancer, 2023, 30 (6), ⟨10.1530/erc-22-0395⟩

Article dans une revue hal-04489844v1
Deposit thumbnail

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?

Antoine Coupier , Yves Gallien , Olivier Boillot , Thomas Walter , Olivier Guillaud et al.

Clinical Transplantation, 2023, 37 (1), pp.e14841. ⟨10.1111/ctr.14841⟩

Article dans une revue hal-04183824v1
Deposit thumbnail

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours

Thomas Walter , Marine Perrier , Jean-Yves Scoazec

Therapeutic Advances in Medical Oncology, 2023, 15, pp.175883592311710. ⟨10.1177/17588359231171041⟩

Article dans une revue (article de synthèse) hal-04489754v1

EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standard

Milenea Muzzolini , Thomas Walter , Sébastien Gaujoux

Gastrointestinal Endoscopy, 2023, 98 (6), pp.1039-1040. ⟨10.1016/j.gie.2023.07.023⟩

Article dans une revue hal-04490396v1
Deposit thumbnail

Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognostic factors and surgical procedure?

Léa Robin , Alain Sauvanet , Thomas Walter , Haythem Najah , Massimo Falconi et al.

Surgery, 2023, 173 (5), pp.1144-1152. ⟨10.1016/j.surg.2022.12.030⟩

Article dans une revue hal-04489743v1
Deposit thumbnail

The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

Maroin Kalifi , Sophie Deguelte , Matthieu Faron , Pauline Afchain , Louis de Mestier et al.

Annals of Surgical Oncology, 2023, 30 (13), pp.8528-8541. ⟨10.1245/s10434-023-14276-8⟩

Article dans une revue hal-04490380v1

High Tumor Uptake on 18 F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network

Ophélie de Rycke , Marine Perrier , Éric Ouvrard , Clément Mennetrey , Choaib Lachachi et al.

Journal of Nuclear Medicine, 2023, 64 (11), pp.1699-1705. ⟨10.2967/jnumed.123.265584⟩

Article dans une revue hal-04490390v1

European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for appendiceal neuroendocrine tumours ( aNET )

Gregory Kaltsas , Thomas Walter , Ulrich Knigge , Christos Toumpanakis , Ana Santos et al.

Journal of Neuroendocrinology, 2023, 35 (10), ⟨10.1111/jne.13332⟩

Article dans une revue hal-04489826v1
Deposit thumbnail

Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study

Aziz Zaanan , Julie Henriques , Anthony Turpin , Sylvain Manfredi , Romain Coriat et al.

JNCI Cancer Spectrum, 2023, 7 (5), pkad064. ⟨10.1093/jncics/pkad064⟩

Article dans une revue hal-04282951v1

Carcinoid heart disease in patients with midgut neuroendocrine tumours

Clémence Delhomme , Thomas Walter , Dimitri Arangalage , Gaspard Suc , Olivia Hentic et al.

Journal of Neuroendocrinology, 2023, 35 (4), ⟨10.1111/jne.13262⟩

Article dans une revue hal-04489852v1

Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial

Thomas Walter , Astrid Lievre , Romain Coriat , David Malka , Farid Elhajbi et al.

Lancet Oncology, 2023, 24 (3), pp.297-306. ⟨10.1016/s1470-2045(23)00001-3⟩

Article dans une revue hal-04489738v1
Deposit thumbnail

Necrosis as a strong independent prognostic factor required in the implementation of pathological reporting for pancreatic adenocarcinoma resection specimens

Tanguy Fenouil , Pierre Marie Lavrut , Maud Rabeyrin , Mustapha Adham , Kayvan Mohkam et al.

Pathology - Research and Practice, 2023, 244, pp.154406. ⟨10.1016/j.prp.2023.154406⟩

Article dans une revue hal-04168612v1
Deposit thumbnail

Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database

Marine Perrier , Charbel Mouawad , Delphine Gueguen , Benoit Thomé , Maryse Lapeyre-Mestre et al.

Clinics and Research in Hepatology and Gastroenterology, 2023, 47 (7), pp.102177. ⟨10.1016/j.clinre.2023.102177⟩

Article dans une revue hal-04489768v1

<sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors

Eric Ouvrard , Louis de Mestier , Caroline Boursier , Boumediene Lachachi , Nicolas Sahakian et al.

Journal of Nuclear Medicine, 2022, 63 (12), pp.1865-1870. ⟨10.2967/jnumed.122.263984⟩

Article dans une revue hal-03954228v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis within the lungNENomics Project

A. Sexton-Oates , A. Di Genova , L. Mangiante , C. Voegele , Séverine Tabone-Eglinger et al.

Journal of Thoracic Oncology, 2022, 17 (9), pp.S45-S46

Article dans une revue cea-04352533v1

887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial

E. Baudin , Thomas Walter , A. Beron , D. Smith , J. Hadoux et al.

Annals of Oncology, 2022, 33, pp.S954. ⟨10.1016/j.annonc.2022.07.1013⟩

Article dans une revue hal-04490313v1

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Frederic Mercier , Guillaume Passot , Pierre‐emmanuel Bonnot , Peter Cashin , Wim Ceelen et al.

World Journal of Surgery, 2022, 46 (6), pp.1336-1343. ⟨10.1007/s00268-022-06498-w⟩

Article dans une revue hal-04490255v1

Second-Line Treatment and Prognostic Factors in Neuroendocrine Carcinoma.

Julien Hadoux , Thomas Walter , Christina Kanaan , Ségolène Hescot , Vincent Hautefeuille et al.

Endocrine-Related Cancer, 2022, 29 (10), p.569-580. ⟨10.1530/ERC-22-0102⟩

Article dans une revue hal-03746086v1

Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion

Adrien Patenotte , Clara Yzet , Timothée Wallenhorst , Fabien Subtil , Sarah Leblanc et al.

Endoscopy, 2022, 55 (02), pp.192-197. ⟨10.1055/a-1866-8080⟩

Article dans une revue hal-04500038v1
Deposit thumbnail

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study

Côme Lepage , J-M. Phelip , Astrid Lièvre , Karine Le Malicot , L Dahan et al.

European Journal of Cancer, 2022, 175, pp.31-40. ⟨10.1016/j.ejca.2022.07.033⟩

Article dans une revue hal-03810530v1

Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study

Marine Perrier , Stéphanie Polazzi , Annie Lemelin , Violaine Fernandez , Stéphanie Labonne et al.

Journal of Neuroendocrinology, 2022, 34 (4), ⟨10.1111/jne.13092⟩

Article dans une revue hal-04151010v1
Deposit thumbnail

Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease

Clément Mennetrey , Maëlle Le Bras , Aurélie Bando-Delaunay , Laure Al-Mansour , Magalie Haissaguerre et al.

Journal of Clinical Endocrinology and Metabolism, 2022, 107 (5), pp.e2056-e2064. ⟨10.1210/clinem/dgab891⟩

Article dans une revue hal-03662789v1

Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.

Xixi Ye-Tran , Mohamed Bouattour , Audrey Perret , Anthony Turpin , Thomas Walter et al.

Journal of Clinical Oncology, 2022, 40 (16_suppl), pp.e16194-e16194. ⟨10.1200/JCO.2022.40.16_suppl.e16194⟩

Article dans une revue hal-04489869v1
Deposit thumbnail

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis

Roy Hajjar , Frederic Mercier , Guillaume Passot , Arnaud Pasquer , Maximiliano Gelli et al.

EJSO - European Journal of Surgical Oncology, 2022, 48 (7), pp.1626-1630. ⟨10.1016/j.ejso.2022.03.019⟩

Article dans une revue hal-04490265v1

Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

Nicolas Benech , Sylvie Bonvalot , Armelle Dufresne , Afshin Gangi , Cécile Le Péchoux et al.

Digestive and Liver Disease, 2022, 54 (6), pp.737-746. ⟨10.1016/j.dld.2022.03.004⟩

Article dans une revue hal-03925724v1

Efficacy of EUS-guided hepaticogastrostomy in prolonging survival of patients with perihilar cholangiocarcinoma

Armelle Schoch , Andrea Lisotti , Thomas Walter , Fabien Fumex , Sarah Leblanc et al.

Endoscopic Ultrasound, 2022, 11 (6), pp.487. ⟨10.4103/eus-d-22-00014⟩

Article dans une revue hal-04490222v1

Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability

Claire Boyer , David Sefrioui , Romain Cohen , Romain Chautard , Marine Perrier et al.

Digestive and Liver Disease, 2022, ⟨10.1016/j.dld.2022.03.011⟩

Article dans une revue hal-03731980v1

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease

M. Flagiello , M. Pozzi , L. Francois , A. Al Harthy , J. Forestier et al.

Cardiovascular Revascularization Medicine, 2022, 40s, pp.130-134. ⟨10.1016/j.carrev.2021.12.027⟩

Article dans une revue inserm-03831063v1

Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors

Paul Girot , Eric Baudin , Hélène Senellart , Nadia Bouarioua , Olivia Hentic et al.

Neuroendocrinology, 2022, 112 (6), pp.537-546. ⟨10.1159/000518650⟩

Article dans une revue hal-04490284v1
Deposit thumbnail

Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort

Gaël Roth , Yohan Fayet , Sakina Benmameche-Medjahed , Françoise Ducimetière , Amandine Charreton et al.

Cancers, 2022, 14 (21), pp.5413. ⟨10.3390/cancers14215413⟩

Article dans une revue hal-04490226v1

Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study

Sébastien Gaujoux , Guillaume Martin , Eric Mirallié , Nicolas Regenet , Maëlle Le Bras et al.

British Journal of Surgery, 2022, 109 (9), pp.872-879. ⟨10.1093/bjs/znac006⟩

Article dans une revue hal-03883938v1

Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence

Carole Morin , Keo-Morakort Benedetto , Agathe Deville , Laurent Milot , Aurélie Theillaumas et al.

Endocrine Connections, 2022, 11 (6), ⟨10.1530/EC-22-0097⟩

Article dans une revue hal-04490245v1

ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study

Laura Gerard , Jessica Garcia , Arnaud Gauthier , Jonathan Lopez , Alice Durand et al.

Neuroendocrinology, 2021, ⟨10.1159/000512502⟩

Article dans une revue hal-02999436v1

Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer et al.

Annals of translational medicine, 2021, 9 (1), pp.50-50. ⟨10.21037/atm-20-3474⟩

Article dans une revue hal-04492172v1

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome

Laura Gerard , David Barthelemy , Arnaud Gauthier , Valerie Hervieu , Jonathan Lopez et al.

Endocrine Oncology, 2021, 1 (1), pp.K1-K6. ⟨10.1530/eo-21-0012⟩

Article dans une revue hal-04492472v1
Deposit thumbnail

Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature

K. Hodroj , D. Barthelemy , J.-C. Lega , G. Grenet , M.-C. Gagnieu et al.

ESMO Open, 2021, 6 (3), pp.100125. ⟨10.1016/j.esmoop.2021.100125⟩

Article dans une revue hal-04492195v1
Deposit thumbnail

FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin

Julien Hadoux , Pauline Afchain , Thomas Walter , David Tougeron , Vincent Hautefeuille et al.

Digestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩

Article dans une revue hal-03333521v1

Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first‐line treatment in patients with metastatic pancreatic adenocarcinoma ( GATE 1)

Eric Assenat , Laurent Mineur , Caroline Mollevi , Evelyne Lopez-Crapez , Catherine Lombard-Bohas et al.

International Journal of Cancer, 2021, 148 (3), pp.682-691. ⟨10.1002/ijc.33225⟩

Article dans une revue hal-03670041v1

Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low‐risk tumours are not associated with lymph node metastases

Nicolas Benech , Jean Marc O'Brien , Maximilien Barret , Jéremie Jacques , Gabriel Rahmi et al.

United European Gastroenterology Journal, 2021, 9 (3), pp.362-369. ⟨10.1177/2050640620958903⟩

Article dans une revue hal-04470221v1

Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors

Ophélie de Rycke , Thomas Walter , Marine Perrier , Olivia Hentic , Catherine Lombard-Bohas et al.

Endocrine-Related Cancer, 2021, 28 (7), pp.457-466. ⟨10.1530/erc-21-0034⟩

Article dans une revue hal-04492482v1

Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study

Louis de Mestier , Frédérique Savagner , Hedia Brixi , Christine Do Cao , Sophie Dominguez-Tinajero et al.

Journal of Clinical Endocrinology and Metabolism, 2021, 106 (4), pp.e1673-e1682. ⟨10.1210/clinem/dgaa924⟩

Article dans une revue hal-03287271v1

Unifocal versus multiple ileal neuroendocrine tumors location: an embryological origin

Maroin Kalifi , Thomas Walter , Laurent Milot , Valérie Hervieu , Ingrid Millot et al.

Neuroendocrinology, 2021, ⟨10.1159/000511849⟩

Article dans une revue hal-02999432v1
Deposit thumbnail

Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)

Anne-Sophie Belmont , Christophe Sajous , Amandine Bruyas , Sara Calattini , Stéphanie Cartalat et al.

Cancers, 2021, 14 (1), pp.29. ⟨10.3390/cancers14010029⟩

Article dans une revue hal-04490309v1

Value of a patient-reported-outcome measure of carcinoid syndrome symptoms

Juliette Maurel , Rosine Guimbaud , Thierry Lecomte , Astrid Lièvre , Vincent Hautefeuille et al.

European Journal of Endocrinology, 2021, 184 (5), pp.711-722. ⟨10.1530/EJE-20-1138⟩

Article dans une revue hal-04179679v1
Deposit thumbnail

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database

Christelle de la Fouchardière , Mustapha Adham , Anne-Marie Marion-Audibert , Antoine Duclos , Claude Darcha et al.

Cancers, 2021, 13 (14), pp.3515. ⟨10.3390/cancers13143515⟩

Article dans une revue hal-04492495v1
Deposit thumbnail

Targeting netrin‐3 in small cell lung cancer and neuroblastoma

Shan Jiang , Mathieu Richaud , Pauline Vieugué , Nicolas Rama , Jean‐guy Delcros et al.

EMBO Molecular Medicine, 2021, 13 (4), ⟨10.15252/emmm.202012878⟩

Article dans une revue hal-03410529v1
Deposit thumbnail

Principles of Surgical Management of Small Intestinal NET

Arnaud Pasquer , Thomas Walter , Laurent Milot , Valérie Hervieu , Gilles Poncet

Cancers, 2021, 13 (21), pp.5473. ⟨10.3390/cancers13215473⟩

Article dans une revue hal-04492163v1
Deposit thumbnail

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Melissa Frizziero , Alice Durand , Rodrigo Taboada , Elisa Zaninotto , Claudio Luchini et al.

Cancers, 2021, 13 (16), pp.4152. ⟨10.3390/cancers13164152⟩

Article dans une revue hal-04492480v1
Deposit thumbnail

Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Julien Hadoux , Christina Kanaan , Alice Durand , Segolene Hescot , Vincent Hautefeuille et al.

European journal of cancer, 2021, 152, pp.100-115. ⟨10.1016/j.ejca.2021.04.030⟩

Article dans une revue hal-03600262v1
Deposit thumbnail

Efficacy of treatments for VIPoma: A GTE multicentric series

Mathias Brugel , Thomas Walter , Bernard Goichot , Denis Smith , Côme Lepage et al.

Pancreatology, 2021, 21 (8), pp.1531-1539. ⟨10.1016/j.pan.2021.08.001⟩

Article dans une revue hal-04492502v1

Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms

Servane Gay-Chevallier , Louis de Mestier , Julie Perinel , Julien Forestier , Valérie Hervieu et al.

Neuroendocrinology, 2021, 111 (8), pp.718-727. ⟨10.1159/000508102⟩

Article dans une revue hal-04179693v1

Endoscopic ultrasound-guided gastrostomy to avoid interposed digestive loop is effective when lack of transillumination prevents percutaneous approach

Juliette Maurel , Gaspard Bertrand , Florian Beoletto , Thierry Ponchon , Thomas Walter et al.

Endoscopy, 2020, 52 (11), pp.E402-E403. ⟨10.1055/a-1149-1224⟩

Article dans une revue hal-04493508v1
Deposit thumbnail

Chemotherapy in resected neuroendocrine carcinomas of the digestive

Anna Pellat , Thomas Walter , Jeremy Augustin , Vincent Hautefeuille , Olivia Hentic et al.

Neuroendocrinology, 2020, 110 (5), pp.404-412. ⟨10.1159/000502825⟩

Article dans une revue hal-02996214v1
Deposit thumbnail

Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma

Thomas Couronne , Paul Girot , Julien Hadoux , Thierry Lecomte , Alice Durand et al.

Endocrine Connections, 2020, 9 (6), pp.498-505. ⟨10.1530/ec-20-0192⟩

Article dans une revue hal-04492751v1

Endoscopic characterization of rectal neuroendocrine tumors with virtual chromoendoscopy: differences between benign and malignant lesions

Florian Veyre , Thomas Lambin , Caroline Fine , Tanguy Fenouil , Florian Rostain et al.

Endoscopy, 2020, 53 (06), pp.E215-E216. ⟨10.1055/a-1244-9526⟩

Article dans une revue hal-04491996v1

Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection

Emmanuel Forté , Bérénice Petit , Thomas Walter , Vincent Lépilliez , Geoffroy Vanbiervliet et al.

Endoscopy, 2020, 52 (06), pp.444-453. ⟨10.1055/a-1117-3166⟩

Article dans une revue hal-04179697v1

Cost-effectiveness of Lutetium [ 177 Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France

O. Leeuwenkamp , J. Smith-Palmer , R. Ortiz , A. Werner , W. Valentine et al.

Journal of Medical Economics, 2020, 23 (12), pp.1534-1541. ⟨10.1080/13696998.2020.1830286⟩

Article dans une revue hal-04492707v1
Deposit thumbnail

Metformin and everolimus in neuroendocrine tumours: A synergic effect?

Lucia Hue-Fontaine , Annie Lemelin , Julien Forestier , Gerald Raverot , Laurent Milot et al.

Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.954 - 960. ⟨10.1016/j.clinre.2020.02.011⟩

Article dans une revue hal-03492643v1

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors

Marine Perrier , Olivia Hentic , Thomas Walter , Christine Do Cao , Guillaume Cadiot et al.

Digestive and Liver Disease, 2020, 52 (12), pp.1521-1524. ⟨10.1016/j.dld.2020.09.001⟩

Article dans une revue hal-04492690v1
Deposit thumbnail

Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer

Thomas Walter , Neil Hawkins , Richard Pollock , Fabien Colaone , Suki Shergill et al.

Journal of Cancer Research and Clinical Oncology, 2020, 146 (10), pp.2575-2587. ⟨10.1007/s00432-020-03315-6⟩

Article dans une revue hal-04492656v1

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Louis de Mestier , Come Lepage , Eric Baudin , Romain Coriat , Frédéric Courbon et al.

Digestive and Liver Disease, 2020, 52 (5), pp.473-492. ⟨10.1016/j.dld.2020.02.011⟩

Article dans une revue hal-04492748v1
Deposit thumbnail

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier , Thomas Walter , Camille Evrard , Paul de Boissieu , Olivia Hentic et al.

Neuroendocrinology, 2020, 110 (1-2), pp.83-91. ⟨10.1159/000500862⟩

Article dans une revue hal-04492743v1

Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors

Maximilien Minon , Clothilde Soriano , David Morland , Thomas Walter , Côme Lepage et al.

Endocrine, 2020, 67, pp.243-251. ⟨10.1007/s12020-019-02095-5⟩

Article dans une revue hal-02478376v1

Extrapulmonary poorly differentiated NECs, including molecular and immune aspects

Mairéad Mcnamara , Jean-Yves Scoazec , Thomas Walter

Endocrine-Related Cancer, 2020, 27 (7), pp.R219-R238. ⟨10.1530/erc-19-0483⟩

Article dans une revue hal-04493496v1

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

Mohid Khan , Thomas Walter , Amy Buchanan-Hughes , Emma Worthington , Lucie Keeber et al.

World Journal of Gastroenterology, 2020, 26 (30), pp.4537-4556. ⟨10.3748/wjg.v26.i30.4537⟩

Article dans une revue hal-04492712v1

Diagnostic endoscopic submucosal dissection with targeted tunnel to reach the suspect area first in order to diagnose muscular invasion and differentiate T1b from T2 cancers

Camille Meunier , Jérémie Jacques , Jérôme Rivory , Thomas Lambin , Thomas Walter et al.

Endoscopy, 2020, 53 (08), pp.870-871. ⟨10.1055/a-1268-7057⟩

Article dans une revue hal-04470335v1

Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study

Annie Lemelin , Delphine Maucort-Boulch , Elisabeth Castel-Kremer , Julien Forestier , Valérie Hervieu et al.

Neuroendocrinology, 2020, 110 (7-8), pp.653-661. ⟨10.1159/000503901⟩

Article dans une revue hal-04151916v1
Deposit thumbnail

Nonampullary duodenal subepithelial neuroendocrine tumor removed R0 by endoscopic submucosal dissection with double clips and rubber band traction

Borathchakra Oung , Thomas Walter , Valérie Hervieu , Jérémie Jacques , Mathieu Pioche

VideoGIE, 2019, 4 (12), pp.570-573. ⟨10.1016/j.vgie.2019.08.006⟩

Article dans une revue hal-04493877v1
Deposit thumbnail

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres

Melissa Frizziero , Xin Wang , Bipasha Chakrabarty , Alexa Childs , Tu Luong et al.

World Journal of Gastroenterology, 2019, 25 (39), pp.5991-6005. ⟨10.3748/wjg.v25.i39.5991⟩

Article dans une revue hal-04493932v1
Deposit thumbnail

Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases

V. Kepenekian , A. Muller , P. Valette , P. Rousset , M. Chauvenet et al.

BJS Open, 2019, 3 (3), pp.344-353. ⟨10.1002/bjs5.50140⟩

Article dans une revue hal-04493892v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Louis de Mestier , Thomas Walter , Hedia Brixi , Camille Evrard , Jean-Louis Legoux et al.

Neuroendocrinology, 2019, 108 (4), pp.343-353. ⟨10.1159/000498887⟩

Article dans une revue hal-04493972v1
Deposit thumbnail

Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors

Patrick Robelin , Julien Hadoux , Julien Forestier , David Planchard , Valérie Hervieu et al.

Journal of Thoracic Oncology, 2019, 14, pp.993 - 1002. ⟨10.1016/j.jtho.2019.02.002⟩

Article dans une revue hal-03484938v1

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)

Caroline Fine , Guillaume Roquin , Eric Terrebonne , Thierry Lecomte , Romain Coriat et al.

United European Gastroenterology Journal, 2019, 7 (8), pp.1102-1112. ⟨10.1177/2050640619861883⟩

Article dans une revue hal-02549178v1
Deposit thumbnail

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors

Louis de Mestier , Diane Lorenzo , Caroline Fine , Jérôme Cros , Olivia Hentic et al.

Best Practice and Research: Clinical Endocrinology and Metabolism, 2019, 33, pp.101293 -. ⟨10.1016/j.beem.2019.101293⟩

Article dans une revue hal-03489062v1
Deposit thumbnail

Prognostic and predictive value of nuclear imaging in endocrine oncology

Giorgio Treglia , Bernard Goichot , Luca Giovanella , Elif Hindié , Abhishek Jha et al.

Endocrine, 2019, 67 (1), pp.9-19. ⟨10.1007/s12020-019-02131-4⟩

Article dans une revue hal-04492687v1

Neuropilin‐2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors

Julien Bollard , Céline Patte , Kristina Radkova , Patrick Massoma , Laurence Chardon et al.

Journal of Pathology, 2019, 249 (3), pp.343-355. ⟨10.1002/path.5321⟩

Article dans une revue hal-04653929v1
Deposit thumbnail

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases

Alessio Imperiale , Gilles Poncet , Pietro Addeo , Elisa Ruhland , Colette Roche et al.

Metabolites, 2019, 9 (12), pp.300. ⟨10.3390/metabo9120300⟩

Article dans une revue hal-02923574v1

Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter , Come Lepage , Romain Coriat , Emilie Barbier , Guillaume Cadiot et al.

European Journal of Cancer, 2019, 123, pp.92-100. ⟨10.1016/j.ejca.2019.09.021⟩

Article dans une revue hal-04493861v1

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors : A National Study from the French Group of Endocrine Tumors (GTE)

Bérénice Rault-Petit , Christine Do Cao , Serge Guyétant , Rosine Guimbaud , Vincent Rohmer et al.

Annals of Surgery, 2019, 270 (1), pp.165-171. ⟨10.1097/SLA.0000000000002736⟩

Article dans une revue hal-02547901v1
Deposit thumbnail

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)

Annie Lemelin , Marc Barritault , Valérie Hervieu , Léa Payen , Julien Péron et al.

Digestive and Liver Disease, 2019, 51, pp.595 - 599. ⟨10.1016/j.dld.2019.02.001⟩

Article dans une revue hal-03486315v1
Deposit thumbnail

Computed tomography scan efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study

Stephanie Morgant , Pascal Artru , Ammar Oudjit , Nelson Lourenco , Arnaud Pasquer et al.

Cancer Management and Research, 2018, Volume 10, pp.3825-3831. ⟨10.2147/cmar.S163141⟩

Article dans une revue hal-04493982v1

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells

Julien Bollard , Céline Patte , Patrick Massoma , Isabelle Goddard , Nicolas Gadot et al.

Molecular Cancer Therapeutics, 2018, 17 (1), pp.60-72. ⟨10.1158/1535-7163.MCT-17-0325⟩

Article dans une revue hal-04494066v1

Narrow-band imaging detects synchronous oropharyngeal squamous carcinoma during treatment of an early esophageal squamous cell carcinoma

Alexander Katzarov , Alexandru Lupu , Jérémie Jacques , Jérôme Rivory , Florian Rostain et al.

Endoscopy, 2018, 50 (09), pp.E264-E266. ⟨10.1055/a-0640-2464⟩

Article dans une revue hal-04495732v1

Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease

Jérôme Dumortier , Delphine Maucort-Boulch , Domitille Poinsot , Elsa Thimonier , Christine Chambon-Augoyard et al.

Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (5), pp.427-435. ⟨10.1016/j.clinre.2018.04.011⟩

Article dans une revue hal-04151948v1

A motivational phone call improves participation to screening colonoscopy for those with a positive FIT in a national screening programme (NCT 03276091)

Clémentine Gandilhon , Patricia Soler-Michel , Léa Vecchiato , Claude Chaunier , Isabelle Fay et al.

Digestive and Liver Disease, 2018, 50 (12), pp.1309-1314. ⟨10.1016/j.dld.2018.08.007⟩

Article dans une revue hal-04493977v1

Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine Tumors

Arnaud Plante , Eric Baudin , Christine Do Cao , Olivia Hentic , Olivier Dubreuil et al.

Clinics and Research in Hepatology and Gastroenterology, 2018, 42 (2), pp.153-159. ⟨10.1016/j.clinre.2017.10.003⟩

Article dans une revue hal-04495704v1
Deposit thumbnail

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer et al.

Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩

Article dans une revue hal-04383088v1

An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma

Elisabeth Castel-Kremer , Solene de Talhouet , Anne-Laure Charlois , Emmanuelle Graillot , Xavier Chopin-Laly et al.

Journal of Geriatric Oncology, 2018, 9 (4), pp.373-381. ⟨10.1016/j.jgo.2018.03.007⟩

Article dans une revue hal-04494047v1

Gastric neuroendocrine tumors display deep invasive features, with amorphous pit and irregular vascular pattern, using narrow-band imaging and magnification

Adrien Choné , Thomas Walter , Jérôme Rivory , Pierre-Marie Lavrut , Julien Forestier et al.

Endoscopy, 2018, 50 (08), pp.E199-E201. ⟨10.1055/a-0606-4792⟩

Article dans une revue hal-04494046v1

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia , Julien Forestier , Eric Dusserre , Anne-Sophie Wozny , Florence Geiguer et al.

Oncotarget, 2018, 9 (30), pp.21122-21131. ⟨10.18632/oncotarget.24950⟩

Article dans une revue hal-03625758v1

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study

Thomas Walter , David Malka , Olivia Hentic , Catherine Lombard-Bohas , Karine Le Malicot et al.

Digestive and Liver Disease, 2018, 50 (2), pp.195-198. ⟨10.1016/j.dld.2017.11.020⟩

Article dans une revue istex hal-01699411v1
Deposit thumbnail

Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery

Myrtille Fouché , Yves Bouffard , Mary-Charlotte Le Goff , Johanne Prothet , François Malavieille et al.

Endocrine Connections, 2018, 7 (12), pp.1245-1250. ⟨10.1530/ec-18-0324⟩

Article dans une revue hal-04494027v1

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

Anna Pellat , Chantal Dreyer , Camille Couffignal , Thomas Walter , Catherine Lombard-Bohas et al.

Neuroendocrinology, 2018, 107 (1), pp.24-31. ⟨10.1159/000487237⟩

Article dans une revue hal-04495727v1

Survival and prognostic factors after adjuvant 131iodine-labeled lipiodol for hepatocellular carcinoma: a retrospective analysis of 106 patients over 20 years

Jonathan Olesinski , François Mithieux , Olivier Guillaud , Marie-Noëlle Hilleret , Catherine Lombard-Bohas et al.

Annals of Nuclear Medicine, 2017, 31 (5), pp.379-389. ⟨10.1007/s12149-017-1165-4⟩

Article dans une revue hal-04173123v1

Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines

Margaux Foulfoin , Emmanuelle Graillot , Mustapha Adham , Pascal Rousset , Julien Forestier et al.

Endocrine-Related Cancer, 2017, 24 (2), pp.71-81. ⟨10.1530/erc-16-0464⟩

Article dans une revue hal-04494085v1

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)

Guillaume Roquin , Éric Baudin , Catherine Lombard-Bohas , Guillaume Cadiot , Sophie Dominguez et al.

Neuroendocrinology, 2017, 106 (1), pp.38-46. ⟨10.1159/000457955⟩

Article dans une revue hal-02451453v1

Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments

Thomas Walter , C Zhenzhen Wang , O Guillaud , E Cotte , A Pasquer et al.

United European Gastroenterology Journal, 2017, 5 (5), pp.735-741. ⟨10.1177/2050640616678150⟩

Article dans une revue hal-04495896v1
Deposit thumbnail

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Sylvain Manfredi , Thomas Walter , Eric Baudin , Philippe Ruszniewski , Thierry Lecomte et al.

Endocrine, 2017, 57 (3), pp.504-511. ⟨10.1007/s12020-017-1355-9⟩

Article dans une revue hal-01576810v1

Maintaining quality of life for patients with neuroendocrine tumours

Thomas Walter

Lancet Oncology, 2017, 18 (10), pp.1299-1300. ⟨10.1016/s1470-2045(17)30618-6⟩

Article dans une revue hal-04495910v1
Deposit thumbnail

Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas

Angela Lamarca , Thomas Walter , Marianne Pavel , Ivan Borbath , Patricia Freis et al.

JNCI: Journal of the National Cancer Institute, 2017, 109 (5), pp.djw277. ⟨10.1093/jnci/djw277⟩

Article dans une revue hal-04495933v1

Desmoid Tumors and Celecoxib with Sorafenib

Nicolas Benech , Thomas Walter , Jean-Christophe Saurin

New England Journal of Medicine, 2017, 376 (26), pp.2595-2597. ⟨10.1056/NEJMc1702562⟩

Article dans une revue hal-04495950v1

In Reply

Romain Coriat , Benoît Terris , Thomas Walter

Oncologist, 2017, 22 (3), pp.359-360. ⟨10.1634/theoncologist.2016-0393⟩

Article dans une revue hal-04495937v1

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

T. Walter , T Tougeron , Emmanuel Baudin , K. Le Malicot , T. Lecomte et al.

European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩

Article dans une revue istex hal-01609152v1
Deposit thumbnail

Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers

Patricia Freis , Emmanuelle Graillot , Pascal Rousset , Valérie Hervieu , Laurence Chardon et al.

Scientific Reports, 2017, 7 (1), pp.40609. ⟨10.1038/srep40609⟩

Article dans une revue hal-04500093v1

Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours

Come Lepage , Laetitia Dahan , Nadia Bouarioua , Christos Toumpanakis , Jean-Louis Legoux et al.

Digestive and Liver Disease, 2017, 49 (5), pp.568 - 571. ⟨10.1016/j.dld.2017.02.004⟩

Article dans une revue istex hal-01599909v1
Deposit thumbnail

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines

Patricia Freis , Julien Bollard , Justine Lebeau , Patrick Massoma , Joëlle Fauvre et al.

Oncotarget, 2017, 8 (13), pp.20974-20987. ⟨10.18632/oncotarget.15469⟩

Article dans une revue hal-02379643v1

Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study

Davide Campana , Thomas Walter , Sara Pusceddu , Fabio Gelsomino , Emmanuelle Graillot et al.

Endocrine, 2017, 60 (3), pp.490-498. ⟨10.1007/s12020-017-1474-3⟩

Article dans une revue hal-04494061v1

Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up

C. Nozieres , L. Chardon , Bernard Goichot , F. Borson-Chazot , V. Hervieu et al.

European Journal of Endocrinology, 2016, 174 (3), pp.335-41. ⟨10.1530/EJE-15-0917⟩

Article dans une revue hal-01850353v1

Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors

Thomas Walter , D. Planchard , K. Bouledrak , J.Y. Scoazec , P.J. Souquet et al.

Lung Cancer, 2016, 96, pp.68-73. ⟨10.1016/j.lungcan.2016.03.018⟩

Article dans une revue hal-04495958v1

Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement

J. Perinel , G. Nappo , M. El Bechwaty , Thomas Walter , V. Hervieu et al.

Langenbeck's Archives of Surgery, 2016, 401 (8), pp.1131-1142. ⟨10.1007/s00423-016-1488-y⟩

Article dans une revue hal-04496006v1

Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC , and PTEN genes

Marco Petronio , Stephane Pinson , Thomas Walter , Marie‐odile Joly , Valerie Hervieu et al.

United European Gastroenterology Journal, 2016, 4 (2), pp.305-313. ⟨10.1177/2050640615594939⟩

Article dans une revue hal-04495988v1
Deposit thumbnail

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma

Bertrand Brieau , Céline Lepère , Thomas Walter , Thierry Lecomte , Rosine Guimbaud et al.

Medicine, 2015, 94 (42), pp.e1864. ⟨10.1097/MD.0000000000001864⟩

Article dans une revue hal-01301145v1

Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound

A. Guibal , C. Boularan , M. Bruce , M. Vallin , F. Pilleul et al.

European Radiology, 2013, 23 (4), pp.1138--1149. ⟨10.1007/s00330-012-2692-y⟩

Article dans une revue istex hal-01918694v1

Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation

A. Guibal , T. Lefort , L. Chardon , N. Benslama , S. Mule et al.

European Radiology, 2013, 23 (3), pp.805--815. ⟨10.1007/s00330-012-2646-4⟩

Article dans une revue istex hal-01918695v1

Antitumor Effect of Everolimus in Preclinical Models of High Grade Gastroenteropancreatic Neuroendocrine Carcinomas.

Julien Bollard , Christophe Couderc , Martine Blanc , Gilles Poncet , Florian Lepinasse et al.

Neuroendocrinology, 2013, epub ahead of print. ⟨10.1159/000347063⟩

Article dans une revue hal-00790198v1

Obstructing minute primary endocrine tumor of the main pancreatic duct: diagnostic relevance of endoscopic ultrasonography

R. Gincul , T. Walter , B. Napoleon , C. Lombard-Bohas , C. Partensky et al.

Pancreas, 2012, 41 (1), pp.164--165

Article dans une revue hal-01918698v1

Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation

T. Lefort , F. Pilleul , S. Mule , S. L. Bridal , F. Frouin et al.

Ultrasound in Medicine & Biology, 2012, 38 (6), pp.953--961

Article dans une revue hal-01918702v1

Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases

G. Poncet , V. Hervieu , T. Walter , F. Lepinasse , L. Chardon et al.

Journal of Gastrointestinal Surgery, 2011, 15 (1), pp.101--109

Article dans une revue hal-01918705v1

F-18-FLT and F-18-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours

F. Giammarile , C. Billotey , C. Lombard-Bohas , D. Le Bars , C. Bournaud et al.

Nuclear Medicine Communications, 2011, 32, pp.91-97

Article dans une revue hal-02299115v1

Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

Thomas Walter , Jean-Yves Scoazec , Christophe Couderc , Julien Forestier , Colette Roche et al.

Acta Oncologica, 2011, 50 (5), pp.731-2. ⟨10.3109/0284186X.2011.562919⟩

Article dans une revue hal-00710300v1

Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.

Thomas Walter , Juliette Hommell-Fontaine , Géraldine Gouysse , Céline Pourreyron , Mimoun Nejjari et al.

Neuroendocrinology, 2011, 94 (3), pp.200-8. ⟨10.1159/000328134⟩

Article dans une revue hal-00710320v1

Primary neuroendocrine tumors of the main pancreatic duct: a rare entity.

Thomas Walter , Valérie Hervieu , Mustapha Adham , Rodica Gincul , Gilles Poncet et al.

Virchows Archiv, 2011, 458 (5), pp.537-46. ⟨10.1007/s00428-011-1067-0⟩

Article dans une revue istex hal-00713749v1

Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growth.

Christophe Couderc , Gilles Poncet , Karine Villaume , Martine Blanc , Nicolas Gadot et al.

American Journal of Pathology, 2011, 178 (1), pp.336-44. ⟨10.1016/j.ajpath.2010.11.023⟩

Article dans une revue hal-00710288v1

18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.

Francesco Giammarile , Claire Billotey , Catherine Lombard-Bohas , Didier Le Bars , Claire Bournaud et al.

Nuclear Medicine Communications, 2011, 32 (2), pp.91-7. ⟨10.1097/MNM.0b013e3283412143⟩

Article dans une revue hal-00814028v1

Transcatheter local thrombolysis in patients with extensive TIPS thrombosis

J. Dumortier , T. Walter , O. Guillaud , F. Pietu , M. Vallin et al.

Gastroenterol. Clin. Biol., 2010, 34 (12), pp.721--725

Article dans une revue hal-01918717v1

TIPS thrombosis related to abdominal trauma

F. Pietu , T. Walter , O. Guillaud , F. Pilleul , J. Dumortier

European Journal of Gastroenterology & Hepatology, 2010, 22 (7), pp.883--885

Article dans une revue hal-01918719v1

VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway.

Karine Villaume , Martine Blanc , Géraldine Gouysse , Thomas R. Walter , Christophe Couderc et al.

Neuroendocrinology, 2010, epub ahead of print. ⟨10.1159/000289569⟩

Article dans une revue hal-00475083v1

Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors

T. Walter , D. Bruneton , P. A. Cassier , V. Hervieu , F. Pilleul et al.

Clinical Colorectal Cancer, 2010, 9 (4), pp.248--254

Article dans une revue hal-01918720v1

Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.

Philippe A Cassier , Thomas R. Walter , Beatrice Eymard , Philippe Ardisson , Maurice Perol et al.

Cancer / Cancer (Phila), 2009, epub ahead of print. ⟨10.1002/cncr.24384⟩

Article dans une revue hal-00391942v1

Angiogenesis and tumor progression in neuroendocrine digestive tumors.

Gilles Poncet , Karine Villaume , Thomas Walter , Céline Pourreyron , Aurélie Theillaumas et al.

Journal of Surgical Research, 2009, 154 (1), pp.68-77. ⟨10.1016/j.jss.2008.03.055⟩

Article dans une revue istex hal-00475688v1
Deposit thumbnail

Human blood biomarkers of skeletal muscle atrophy

Coralie Delabrise , Julien Aniort , Cécile Polge , Agnès Claustre , Lydie Combaret et al.

Journées de la Société Française de Myologie 21ème Édition, Société Française de Myologie, Nov 2024, Clermont - Ferrand, France

Communication dans un congrès hal-04992128v1

Characterisation, prognosis, and treatment of patients with locally advanced or metastatic thymic carcinoid tumor: A retrospective study of the French GTE-ENDOCAN RENATEN and RYTHMIC networks

Thomas Walter

19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.73

Communication dans un congrès hal-04490299v1

Etoposide-based rechallenge and second/third line treatments in patients with metastatic neuroendocrine carcinoma: Results from the multicenter RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network

Thomas Walter

19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.111

Communication dans un congrès hal-04490282v1

LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study

Thomas Walter , A. Lievre , R. Coriat , D. Malka , F. El Hajbi et al.

Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, Sep 2022, Paris, France. pp.S1412, ⟨10.1016/j.annonc.2022.08.045⟩

Communication dans un congrès hal-04489922v1

Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study)

Thomas Walter

19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.186

Communication dans un congrès hal-04490234v1

Surgical management of patients with sporadic Zollinger-Ellison Syndrome: An ACHBT and GTE study

Thomas Walter

19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.195

Communication dans un congrès hal-04490290v1

Characterising aggressive pulmonary carcinoids through integrative omics analysis

Thomas Walter

19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.29

Communication dans un congrès hal-04489996v1

LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

N. Girard , J. Mazieres , J. Otto , H. Lena , C. Lepage et al.

Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩

Communication dans un congrès hal-04492251v1

OPERA: Observational study of perception of information and quality of life (QoL) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) starting Lanreotide Autogel (LAN)

Thomas Walter

18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.136

Communication dans un congrès hal-04492200v1

Cost of carcinoid syndrome (CS) In France: Analysis of the national health insurance database

Thomas Walter

18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.76

Communication dans un congrès hal-04492045v1

Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: A GTE study

Thomas Walter

18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.104

Communication dans un congrès hal-04492492v1

Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumors - An international double-blind, placebo-controlled randomized phase 2. Prodige 31 REMINET. A FFCD study

Thomas Walter

18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.139

Communication dans un congrès hal-04492188v1

Prognosis and the role of Rb expression in metastatic grade 3 neuroendocrine carcinoma (G3NEC), results from the multicenter retrospective RbNEC study

Thomas Walter

18th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Feb 2021, Virtual conference, Germany. pp.107

Communication dans un congrès hal-04492213v1

Patient and Nurse Satisfaction with the New Lanreotide Autogel Pre-Filled Syringe in Neuroendocrine Tumors (NET): A Prospective Study (SONATE)

Thomas Walter

17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.H30

Communication dans un congrès hal-04493487v1

Dacarbazine- or Temozolomide-Based Chemotherapy in Metastatic Digestive Neuroendocrine Carcinomas in Post First-line Chemotherapy: A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE)

Thomas Walter

17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H08)

Communication dans un congrès hal-04493659v1

Differential Diagnosis (DDX) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter

12th Annual Multidisciplinary Neuroendocrine Tumor Medical Symposium of the North American Neuroendocrine Tumor Society, Oct 2019, Boston (MA), United States. pp.472

Communication dans un congrès hal-04493548v1

Impact of Small Cell (SC) versus (vs.) Non-Small Cell (nSC) Morphology on Outcomes of Patients (pts) with Extra-Pulmonary, Poorly Differentiated Neuroendocrine Carcinoma (EP-PD-NEC)

Thomas Walter

Abstracts of the 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Barcelona (ES), Spain. pp.(J25)

Communication dans un congrès hal-04492643v1

OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel-Baseline Characteristics

Thomas Walter

17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(D23)

Communication dans un congrès hal-04493628v1

The PanNENomics Project: A Call for an International Collaborative Effort Built on the Success of the LungNENomics Project

Thomas Walter

17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(C08)

Communication dans un congrès hal-04493635v1

A systematic review and exploratory network meta-analysis of third-line treatments for metastatic colorectal cancer

Thomas Walter

ISPOR 2020 HEOR: Advancing Evidence to Action, May 2020, Orlando (FL), United States. pp.S30

Communication dans un congrès hal-04492668v1

Efficacy of Alkylating Agent Re-challenge after Therapeutic Pause in Metastatic Pancreatic Neuroendocrine Tumors (PanNET)

Thomas Walter

17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2020, Virtual conference, Germany. pp.(H11)

Communication dans un congrès hal-04493642v1

The Effect of Carcinoid Syndrome Diarrhea (CSD) Interventions on Patient Experience Outcomes: A Systematic Literature Review (SLR)

Thomas Walter

16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelone (ES), Spain. pp.(J15)

Communication dans un congrès hal-04493864v1

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Thomas Walter

16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), France. pp.(H07)

Communication dans un congrès hal-04495625v1

Temozolomide (TEM) vs Temozolomide-Capecitabine (CAP) in Advanced Pancreatic NET (pNET): A Multicenter Retrospective Analysis of 138 Patients Using a Propensity Score

Thomas Walter

6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(H08)

Communication dans un congrès hal-04495620v1

Differential Diagnosis (DDx) of Carcinoid Syndrome Diarrhea (CSD): A Systematic Literature Review (SLR)

Thomas Walter

16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(J08)

Communication dans un congrès hal-04493888v1

Framework synthesis of qualitative and quantitative evidence to explore the differential diagnosis of diarrhea in neuroendocrine tumor patients

Thomas Walter

ISPOR 2019: Rapid. Disruptive. Innovative: A New Era in HEOR, May 2019, Nouvelle Orléans (LA), United States. pp.S265

Communication dans un congrès hal-04493855v1

Carcinoid heart disease (CHD): the CRUSOE-NETs, a prospective cohort study from the French group of endocrine tumours (GTE)

K. Dekeister Geoffroy , L. Francois , Thomas Walter , O. Hentic Dhome , A. Cachier et al.

44th ESMO Congress (ESMO 2019), Sep 2019, Barcelona (ES), Spain. pp.v196, ⟨10.1093/annonc/mdz245.007⟩

Communication dans un congrès hal-04493904v1

Endoscopic Management of 345 Small Rectal Neuroendocrine Tumours: A National Study from the French Group of Endocrine Tumours (GTE)

Thomas Walter

16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2019, Barcelona (ES), Spain. pp.(G01)

Communication dans un congrès hal-04495616v1

Everolimus after transarterial liver therapy of metastases from gastrointestinal neuroendocrine tumors: The FFCD 1104-EVACEL-GTE phase II study

Thomas Walter

43rd ESMO Congress (ESMO 2018), Mar 2018, Munich (Allemagne), Germany. pp.viii469

Communication dans un congrès hal-04495683v1

Patient Survey Devoted to Characterizing Experience and Expectations of Patients with Neuroendocrine Tumors (NET)

Thomas Walter

15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(D59)

Communication dans un congrès hal-04495692v1

Perioperative Chemotherapy in Resectable Neuroendocrine Carcinomas of the Digestive Tract

Thomas Walter

15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2018, Barcelona (ES), Spain. pp.(H20)

Communication dans un congrès hal-04495718v1

Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancreatic (GEP) tract: A multicentre retrospective study

M. Frizziero , X. Wang , B. Chakrabarty , A. Childs , T.V. Luong et al.

42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.155, ⟨10.1093/annonc/mdx368.038⟩

Communication dans un congrès hal-04500086v1

Comparison of performances of three technologies for detection of RAS mutations in cfDNA (NGS strategy, BEAMing assay and ddPCR BioRAD assay)

J. Garcia , J. Forestier , E. Dusserre , C. Rodriguez-Lafrasse , V. Cheynet et al.

42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid (ES), Spain. pp.197, ⟨10.1093/annonc/mdx393.107⟩

Communication dans un congrès hal-04499713v1

Treatment of Metastatic Pancreatic Neuroendocrine Tumors: Relevance of ENETS 2016 Guidelines

Thomas Walter

14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone (ES), Spain. pp.(J6)

Communication dans un congrès hal-04500118v1

Intraoperative Carcinoid Syndrome during Small-Bowel NET Surgery: Description, Prevalence and Risk Factors

Thomas Walter

14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R6)

Communication dans un congrès hal-04504145v1

Patient-Reported Preferences in Treatments Approved in Neuroendocrine Tumors: A National Survey from the French Group of Endocrine Tumors

Thomas Walter

14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(R12)

Communication dans un congrès hal-04495920v1

Implication of Neuropilin-2 in the Progression of Small Intestinal Neuroendocrine Tumors: Towards a Promising Therapeutic Target

Thomas Walter

14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelona (ES), Spain. pp.(A2)

Communication dans un congrès hal-04504139v1

REMINET : A European, Multicenter, Phase II/III Randomized Double-Blind, Placebo-Controlled Study Evaluating Lanreotide As Maintenance Therapy after First-Line Treatment in Patients with Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors

C. Lepage , L. Dahan , J.-L. Legoux , K. Le Malicot , R. Guimbaud et al.

The 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2017, Barcelone, Spain. pp.187 (J8)

Communication dans un congrès hal-01664217v1

FFCD Prodige 31 Reminnet

Côme Lepage , L. Dahan , Jean-Louis Legoux , Karine Le Malicot , Rosine Guimbaud et al.

The 14th Annual ENETS Conference, Mar 2017, Barcelone, Spain. , 2017, ⟨10.13140/RG.2.2.35427.35368⟩

Poster de conférence hal-01578731v1
Deposit thumbnail

MISE EN PLACE ET EVALUATION D'UNE ACTIVITE DE PHARMACIE CLINIQUE EN HOPITAL DE JOUR ONCOLOGIQUE

Fiona Malagutti , Rémi Faure , Thomas Walter , Julien Forestier , Catherine Lombard-Bohas et al.

Xémes Journées de la Société Française de Pharmacie Oncologique, Oct 2015, Nantes, France

Poster de conférence hal-01214190v1